Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum

Neurological Research

Volumn 32, Issue 2, 2010, Pages 166-172

  Edalatmanesh, Mohammad Amin ^a   Matin, Maryam M ^a   Neshati, Zeinab ^a   Bahrami, Ahmad Reza ^a   Kheirabadi, Masoumeh ^a  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Huntington's disease; Mesenchymal stem cells; Systemic transplantation

Indexed keywords

APOMORPHINE; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ISOLATION; COGNITIVE DEFECT; CONTROLLED STUDY; HUNTINGTON CHOREA; JUGULAR VEIN; MALE; MAZE TEST; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR DYSFUNCTION; NEOSTRIATUM; NONHUMAN; RAT; ANIMAL; CELL CULTURE; COGNITION DISORDERS; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; MOTOR SKILLS DISORDERS; PATHOLOGY; PROCEDURES; WISTAR RAT;

ANIMALS; CELLS, CULTURED; COGNITION DISORDERS; INJECTIONS, INTRAVENOUS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR SKILLS DISORDERS; NEOSTRIATUM; RATS; RATS, WISTAR;

EID: 77949471750     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X409025     Document Type: Article

References (38)

1. Picconi B, Passino E, Sgobio C, et al. Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons. Neurobiol Dis 2006; 22: 143-152
2. Vonsattel J, DiFiglia M. Huntington's disease. J Neuropathol Exp Neurol 1998; 57: 369-384
3. Lawrence AD, Hodges JR, Rosser AE, et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998; 121: 1329-1341
4. Li SH, Li XJ. Huntington-protein interactions and the pathogenesis of Huntington's disease. Trends Genet 2004; 20: 146-154
5. Carter RJ, Lione LA, Humby T, et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 1999; 19: 3248-3257
6. Lione LA, Carter RJ, Hunt MJ, et al. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci 1999; 19: 10428-10437
7. Armstrong RJ, Svendsen CN. Neural stem cells: From cell biology to cell replacement. Cell Transplant 2000; 9: 139-152
8. Bjorklund A. Cell replacement strategies for neurodegenerative disorders. Novartis Found Symp 2000; 231: 7-15
9. Freeman TB, Hauser RA, Sanberg PR, et al. Neural transplantation for the treatment of Huntington's disease. Prog Brain Res 2000; 127: 405-411
10. Peschanski M. 10 years of substitution therapy for neurodegenerative diseases using fetal neuron grafts: A positive outcome but with questions for the future. J Soc Biol 2001; 195: 51-55
11. Svendsen CN, Caldwell MA. Neural stem cells in the developing central nervous system: Implications for cell therapy through transplantation. Prog Brain Res 2000; 127: 13-34
12. Hou LL, Zheng M, Wang DM, et al. Migration and differentiation of human bone marrow mesenchymal stem cells in the rat brain. Acta Physiol Sin 2003; 55: 153-159
13. Lescaudron L, Unni D, Dunbar LG. Autologus adult bone marrow stem cell transplantation in an animal model of Huntington's disease: Behavioral and morphological outcomes. J Neurosci 2003; 113: 945-956
14. Beal MF, Kowall NW, Ellison DW, et al. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 1986; 321: 168-171
15. Chen J, Li Y, Wang L, Lu M, et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 2001; 189: 49-57
16. Hellmann MA, Panet H, Barhum Y, et al. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett 2006; 395: 124-128
17. Hill WD, Hess DC, Martin-Studdard A, et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: Association with bone marrow cell homing to injury. J Neuropathol Exp Neurol 2004; 63: 84-96
18. Baksh D, Davies EJ, Zandstra WP. Adult human bone marrowderived mesenchymal progenitor cells are capable of adhesionindependent survival and expansion. Exp Hematol 2003; 31: 723-732
19. Black BI, Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cell Mol Dis 2001; 27: 632-636
20. Roberts JT, Price SJ, Williams RC, et al. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience 2006; 139: 1187-1199
21. Norman AB, Calderon SF, Giordano M, et al. Striatal tissue transplants attenuate apomorphine-induced rotational behavior in rats with unilateral kainic acid lesions. Neuropharmacology 1988; 27: 333-336
22. McBride JL, Behrstock SP, Chen EY, et al. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol 2004; 475: 211-219
23. Hattori S, Hashimoto R, Miyakawa T, et al. Enriched environments influence depression-related behavior in adult mice and the survival of newborn cells in their hippocampi. Behav Brain Res 2007; 180: 69-76
24. Murphy PK, Carter JR, Lione AL, et al. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci 2000; 20: 5115-5123
25. Lee ST, Chu K, Park JE, et al. Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model. Neurosci Res 2005; 52: 243-249
26. Difiglia M. Excitotoxic injury of the neostriatum: A model for Huntington's disease. Trend Neurosci 1990; 13: 286-289
27. Chen GJ, Jeng CH, Lin SZ, et al. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease. J Biomed Sci 2002; 9: 303-310
28. Zhao LR, Duan WM, Reyes M, et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 2002; 174: 11-20
29. Veizovic T, Beech JS, Stroemer RP, et al. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 2001; 32: 1012-1019
30. Lee ST, Park JE, Lee K, et al. Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease. J Neurosci Methods 2006; 152: 250-254
31. Kim HS, Kang HJ, Park YB. Stem-cell therapy for myocardial diseases. Lancet 2004; 363: 1735
32. Brustle O, Choudhary K, Karram K, et al. Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats. Nat Biotechnol 1998; 16: 1040-1044
33. Chu K, Kim M, Chae SH, et al. Distribution and in situ proliferation patterns of intravenously injected immortalized human neural stem-like cells in rats with focal cerebral ischemia. Neurosci Res 2004; 50: 459-465
34. Jeong SW, Chu K, Jung KH, et al. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 2003; 24: 2258-2263
35. Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery. Neurology 2002; 59: 514-523
36. Edalatmanesh MA, Bahrami AR, Behnam Rasuli M, et al. Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration. Neurol Res 2008; 30: 1086-1090
37. Lawrence AD, Sahakian BJ, Hodges JR, et al. Executive and mnemonic functions in early Huntington's disease. Brain 1996; 119: 1633-1645
38. Shiwach, R. Psychopathology in Huntington's disease patients. Acta Psychiatr Scand 1994; 90: 241-246